Company Filing History:
Years Active: 2022
Title: Huijun Yuan: Innovator in Flavonoid Extraction for Hyperuricemia Treatment
Introduction
Huijun Yuan is a notable inventor based in Fujian, China. He has made significant contributions to the field of pharmacology, particularly in the extraction and application of flavonoids for medical purposes. His innovative work focuses on developing treatments for hyperuricemia, a condition that can lead to gout.
Latest Patents
Huijun Yuan holds a patent for a "Total flavonoids extract of Kitam., preparation method therefor and use thereof for treating hyperuricemia." This patent describes a total flavonoids extract containing 80%-85% of rutin by weight percent content. The results of pharmacological experiments indicate that the extract can lower the activity of xanthine oxidase in the liver of a hyperuricemia model mouse. This reduction in activity leads to a decrease in uric acid synthesis, demonstrating a potential uric acid-lowering effect. The extract is proposed as a potential drug for treating hyperuricemia or gout. The preparation method involves an extraction step, followed by enzymolysis using a specific enzyme composition and ratio. The process concludes with extraction and purification using macroporous resin, achieving an HPLC purity of rutin in the final product.
Career Highlights
Huijun Yuan is associated with Zhangzhou Pien Tze Huang Pharmaceutical Co., Ltd., where he continues to advance his research and development efforts. His work has garnered attention for its potential impact on treating conditions related to elevated uric acid levels.
Collaborations
Huijun Yuan collaborates with colleagues such as Tingting Yin and Fei Hong, contributing to a dynamic research environment focused on innovative pharmaceutical solutions.
Conclusion
Huijun Yuan's contributions to the field of flavonoid extraction and its applications in treating hyperuricemia highlight his role as an influential inventor. His work not only advances scientific knowledge but also offers potential therapeutic options for patients suffering from related conditions.